Stockreport

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting [Yahoo! Finance]

Annexon, Inc. - common stock  (ANNX) 
PDF Pivotal Phase 3 ARCHER II in GA Actively Enrolling with Data Expec ted Second Half 2026 BRISBANE, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANN [Read more]